Kazutaka Higaki

Prof. Dr. Kazutaka Higaki

orcid

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Journal of Controlled Release
Verified
Journal Article
Closed access
TATomoya Araki
Tomoya Araki
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
HSHaruka Suzuki
Haruka Suzuki
RKRie Kawai
Rie Kawai
TWTaka-Ichi Watanabe
Taka-Ichi Watanabe
KHKazutaka Higaki
Kazutaka Higaki

1 January 2013 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
Daisuke InoueDaisuke Inoue
Daisuke Inoue
TFTomoyuki Furubayashi
Tomoyuki Furubayashi
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
TKToshikiro Kimura
Toshikiro Kimura
KHKazutaka Higaki
Kazutaka Higaki
YHYutaka Higashi
Yutaka Higashi
Mucociliary clearance (MC) is an important factor in determining nasal drug absorption and the ciliary beat of ciliated epithelial cells of the nasal mucosa is the driving force of MC. However, the relationship between MC and ciliary beat frequency (CBF) is still ambiguous. The purpose of this study was to establish an evaluation method of CBF as an index of mucociliary function and examine the relationship between MC and CBF. A sequence of images of ciliary beating of an excised rat nasal septum was captured using a high-speed digital video camera. CBF (beats per second, Hz) was determined from periodic changes in the contrast value of a specific location in a sequence of images. CBF under control conditions was 8.49±0.38 Hz, which is similar to values reported for cultured human nasal epithelial cells and rat tracheal cells. β-Adrenergic and cholinergic antagonists decreased CBF, while β-adrenergic agonists and acetylcholine increased CBF. These results were similar with those observed for MC in our previous study. It was found that CBFs were significantly and linearly correlated with MC, indicating that MC is directly regulated by CBF and that this evaluation system allows the quantitative determination of nasal mucociliary function.

17 April 2023 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
KYKeita Yamanouchi
Keita Yamanouchi
TITomoki Ishimaru
Tomoki Ishimaru
TKTakuya Kakuno
Takuya Kakuno
YTYuki Takemoto
Yuki Takemoto
SKSho Kawatsu
Sho Kawatsu
KHKazutaka Higaki
Kazutaka Higaki

1 December 2021 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
TMTakaya Minamisakamoto
Takaya Minamisakamoto
SNShuhei Nishiguchi
Shuhei Nishiguchi
KHKazuki Hashimoto
Kazuki Hashimoto
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
MMMasato Maruyama
Masato Maruyama
KHKazutaka Higaki
Kazutaka Higaki

14 November 2012 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YYYuta Yoshizawa
Yuta Yoshizawa
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
AFAya Fushimi
Aya Fushimi
SAShigeki Abe
Shigeki Abe
KIKeisuke Ishikawa
Keisuke Ishikawa
KHKazutaka Higaki
Kazutaka Higaki

1 January 2016 in European Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
KOKen-Ichi Ogawara
Ken-Ichi Ogawara
TSTaro Shiraishi
Taro Shiraishi
TATomoya Araki
Tomoya Araki
TWTaka-Ichi Watanabe
Taka-Ichi Watanabe
TOTsutomu Ono
Tsutomu Ono
KHKazutaka Higaki
Kazutaka Higaki